OLD Category: Oncology

Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

• Perez-Ruiz E et al.,

Enhanced DNA repair and genomic stability identify a novel HIV related Diffuse Large B‐cell Lymphoma signature

• Maguire A et al.,

Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)

• Lenz HJ et al.,

Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy

• Findlay EG et al.,

Genomic testing in myeloid malignancy

• Docking TR et al.,Int J Lab Hematol.

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial

• Davies A et al.,

Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors

• Ahmad ST et al.,

The Phenotypic Effects of Exosomes Secreted from Distinct Cellular Sources: A Comparative Study based on miRNA Composition

• Ferguson S et al.,

The tech for the next decade: promises andchallenges in genome biology

• Hajirasouliha I, Tilgner HU.

Immune microenvironments differ in immune characteristics and outcome of glioblastoma multiforme

• Zhang B et al.,

Lymph-circulating tumor cells show distinct properties to blood-circulating tumor cells and are efficient metastatic precursors

• Mohammed SI et al.,

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma

• Butterfield LH et al.,